Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells
Brett M. Stevens, Courtney L. Jones, Daniel A. Pollyea, et al.
Nature Cancer (2020) Vol. 1, Iss. 12, pp. 1176-1187
Open Access | Times Cited: 210

Showing 1-25 of 210 citing articles:

BCL2 and MCL1 inhibitors for hematologic malignancies
Andrew W. Roberts, Andrew H. Wei, David C.S. Huang
Blood (2021) Vol. 138, Iss. 13, pp. 1120-1136
Open Access | Times Cited: 142
Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia
Evan Cherry, Diana Abbott, Maria L. Amaya, et al.
Blood Advances (2021) Vol. 5, Iss. 24, pp. 5565-5573
Open Access | Times Cited: 127
Targeting Energy Metabolism in Cancer Stem Cells: Progress and Challenges in Leukemia and Solid Tumors
Courtney L. Jones, Anagha Inguva, Craig T. Jordan
Cell stem cell (2021) Vol. 28, Iss. 3, pp. 378-393
Open Access | Times Cited: 110
The multiple mechanisms of MCL1 in the regulation of cell fate
Hayley Widden, William J. Placzek
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 103
Leukemic stem cells and therapy resistance in acute myeloid leukemia
Patrick Stelmach, Andreas Trumpp
Haematologica (2023) Vol. 108, Iss. 2, pp. 353-366
Open Access | Times Cited: 97
Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation
Yifat Geffen, Shankara Anand, Yo Akiyama, et al.
Cell (2023) Vol. 186, Iss. 18, pp. 3945-3967.e26
Open Access | Times Cited: 70
Hallmarks of cancer stemness
Jia-Jian Loh, Stephanie Ma
Cell stem cell (2024) Vol. 31, Iss. 5, pp. 617-639
Closed Access | Times Cited: 53
A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy
Shanshan Pei, Ian T. Shelton, Austin E. Gillen, et al.
Cancer Discovery (2023) Vol. 13, Iss. 9, pp. 2032-2049
Open Access | Times Cited: 45
Anti-apoptotic MCL-1 promotes long-chain fatty acid oxidation through interaction with ACSL1
Tristen Wright, Meghan E. Turnis, Christy R. Grace, et al.
Molecular Cell (2024) Vol. 84, Iss. 7, pp. 1338-1353.e8
Closed Access | Times Cited: 17
The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistance
Sunil K. Joshi, Tamilla Nechiporuk, Daniel Bottomly, et al.
Cancer Cell (2021) Vol. 39, Iss. 7, pp. 999-1014.e8
Open Access | Times Cited: 98
Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia
Claudie Bosc, Estelle Saland, Aurélie Bousard, et al.
Nature Cancer (2021) Vol. 2, Iss. 11, pp. 1204-1223
Closed Access | Times Cited: 80
Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia
Donia M. Moujalled, Fiona C. Brown, Chong Chyn Chua, et al.
Blood (2022) Vol. 141, Iss. 6, pp. 634-644
Open Access | Times Cited: 63
MLL4 mediates differentiation and tumor suppression through ferroptosis
Shaun Egolf, Jonathan Zou, Amy Anderson, et al.
Science Advances (2021) Vol. 7, Iss. 50
Open Access | Times Cited: 57
Progress in understanding the mechanisms of resistance to BCL-2 inhibitors
Yilan Xu, Haige Ye
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 46
Cancer stem cells: The adventurous journey from hematopoietic to leukemic stem cells
Andreas Trumpp, Simon Haas
Cell (2022) Vol. 185, Iss. 8, pp. 1266-1270
Open Access | Times Cited: 41
Drug Resistance Mechanisms of Acute Myeloid Leukemia Stem Cells
Jialan Niu, Danyue Peng, Lingbo Liu
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 40
Metabolic Regulation of Hematopoietic Stem Cells
Claudia Morganti, Nina Cabezas‐Wallscheid, Keisuke Ito
HemaSphere (2022) Vol. 6, Iss. 7, pp. e740-e740
Open Access | Times Cited: 39
Characterizing cancer metabolism from bulk and single-cell RNA-seq data using METAFlux
Yuefan Huang, Vakul Mohanty, Merve Dede, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 37
Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid Leukemia
Christina Glytsou, Xufeng Chen, Emmanouil Zacharioudakis, et al.
Cancer Discovery (2023) Vol. 13, Iss. 7, pp. 1656-1677
Open Access | Times Cited: 29
Uncovering expression signatures of synergistic drug responses via ensembles of explainable machine-learning models
Joseph D. Janizek, Ayse B. Dincer, Safiye Çelik, et al.
Nature Biomedical Engineering (2023) Vol. 7, Iss. 6, pp. 811-829
Closed Access | Times Cited: 28
Single-cell analysis reveals altered tumor microenvironments of relapse- and remission-associated pediatric acute myeloid leukemia
Hope Mumme, Beena Thomas, Swati S. Bhasin, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 27
A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents
Nicholas J. Short, Muharrem Müftüoǧlu, Faustine Ong, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 26
AVALON: The Italian cohort study on real‐life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia
Elisabetta Todisco, Cristina Papayannidis, Nicola Fracchiolla, et al.
Cancer (2023) Vol. 129, Iss. 7, pp. 992-1004
Open Access | Times Cited: 24
An Overview of Targeted Therapies in Acute Myeloid Leukemia
Sven Turkalj, Felix A. Radtke, Paresh Vyas
HemaSphere (2023) Vol. 7, Iss. 6, pp. e914-e914
Open Access | Times Cited: 22
SLC25A51 decouples the mitochondrial NAD+/NADH ratio to control proliferation of AML cells
Mu‐Jie Lu, Jonathan Busquets, Valeria Impedovo, et al.
Cell Metabolism (2024) Vol. 36, Iss. 4, pp. 808-821.e6
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top